Thermo Fisher Scientific will be at CPHI Barcelona, October 24-26. Find us at booth #3K50 or schedule a meeting today.
This whitepaper provides insight into the changing comparator sourcing landscape, focusing specifically on the instrumental role the Bolar exemption plays in the shift away from dependence on innovators for clinical supplies. Thermo Fisher's Comparator team has the required expertise to leverage the Bolar exemption, providing clients early access to generic / biosimilar drugs.